Logo image of AMRI

ALBANY MOLECULAR RESH INC (AMRI) Stock Price, Quote, News and Overview

NASDAQ:AMRI - Nasdaq - US0124231095

21.74  0 (0%)

After market: 21.74 0 (0%)

AMRI Quote, Performance and Key Statistics

ALBANY MOLECULAR RESH INC

NASDAQ:AMRI (8/31/2017, 8:15:11 PM)

After market: 21.74 0 (0%)

21.74

0 (0%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High22.17
52 Week Low13.01
Market Cap937.43M
Shares43.12M
Float37.08M
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PE23.89
Earnings (Next)N/A N/A
IPON/A N/A


AMRI short term performance overview.The bars show the price performance of AMRI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

AMRI long term performance overview.The bars show the price performance of AMRI in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of AMRI is 21.74 null. In the past month the price increased by 0.23%. In the past year, price increased by 48.4%.

ALBANY MOLECULAR RESH INC / AMRI Daily stock chart

About AMRI

Company Profile

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.

Company Info

ALBANY MOLECULAR RESH INC

26 CORPORATE CIRCLE

ALBANY NY 12212

CEO: William S. Marth

Phone: 518-512-2000

ALBANY MOLECULAR RESH INC / AMRI FAQ

What is the stock price of ALBANY MOLECULAR RESH INC today?

The current stock price of AMRI is 21.74 null.


What is the ticker symbol for ALBANY MOLECULAR RESH INC stock?

The exchange symbol of ALBANY MOLECULAR RESH INC is AMRI and it is listed on the Nasdaq exchange.


On which exchange is AMRI stock listed?

AMRI stock is listed on the Nasdaq exchange.


What is ALBANY MOLECULAR RESH INC worth?

ALBANY MOLECULAR RESH INC (AMRI) has a market capitalization of 937.43M null. This makes AMRI a Small Cap stock.


What are the support and resistance levels for ALBANY MOLECULAR RESH INC (AMRI) stock?

ALBANY MOLECULAR RESH INC (AMRI) has a support level at 21.73 and a resistance level at 21.75. Check the full technical report for a detailed analysis of AMRI support and resistance levels.


Should I buy ALBANY MOLECULAR RESH INC (AMRI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALBANY MOLECULAR RESH INC (AMRI) stock pay dividends?

AMRI does not pay a dividend.


What is the Price/Earnings (PE) ratio of ALBANY MOLECULAR RESH INC (AMRI)?

ALBANY MOLECULAR RESH INC (AMRI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.42).


AMRI Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to AMRI. When comparing the yearly performance of all stocks, AMRI is one of the better performing stocks in the market, outperforming 87.04% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AMRI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AMRI. AMRI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMRI Financial Highlights

Over the last trailing twelve months AMRI reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS decreased by -46.39% compared to the year before.


Industry RankSector Rank
PM (TTM) -8.78%
ROA -4.81%
ROE -18.86%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%60.66%
Sales Q2Q%43.14%
EPS 1Y (TTM)-46.39%
Revenue 1Y (TTM)48.85%

AMRI Ownership and Analysts


Ownership
Inst Owners0%
Ins Owners22.61%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y149.73%
Revenue Next YearN/A